Skip to content
Trial Eligibility
Menu

The Exhale Study: Treating Maternal Depression in an Urban Pediatric Asthma Clinic

NCT06623981

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this clinical trial is to test the effectiveness and implementation of delivering Enhanced Brief Interpersonal Psychotherapy (IPT-B), an evidence-based maternal depression treatment, to mothers of children under the age of 18 in an urban pediatric asthma clinic. Researchers will compare Enhanced IPT-B and supplemented usual care (brief care coordination). The main questions the trial aims to answer are: Does Enhanced IPT-B decrease maternal depressive symptoms? Does Enhanced IPT-B improve child asthma management and health outcomes (exacerbations, symptoms, control)?

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Asthma in Children
  • Depression

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
Any age
Sex
All
Healthy volunteers
Not accepted
Sponsor
Children's National Research Institute
Last updated on ClinicalTrials.gov
February 24, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

District of Columbia · 1

  • Children's National Hospital · Washington D.C., DC

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.